Our new product offering strength is backed by strong R&D. Medley has established state of the art R&D Centre at Mumbai (Formulation) and Tarapur (API) equipped with the latest instruments. We have strong and dedicated team of more than 100 scientists who are focussed on strengthening R&D capability to enhance ANDA and MAA filings for Regulated markets (US & UK) & for other markets. We have In-house capabilities enabling development of wide range of dosage forms and APIs. Our capabilities cover API & Formulation Development, Analytical development, Packaging development and Regulatory affairs.